#JPM24 quick hits: Io­n­is on part­ner­ship’s pros and cons; No­vo Ven­tures has $600M to spend; Are small mol­e­cules back? + more

SAN FRAN­CIS­CO — The bio­phar­ma ex­trav­a­gan­za that is the JP Mor­gan Health­care Con­fer­ence start­ed to wind down Wednes­day. Here’s what we’re hear­ing on Wednes­day around San …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER